Total
0
Shares
Creso Pharma (ASX:CPH) - Creso Pharma - The Market Herald
Creso Pharma
Source: Creso Pharma
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Creso Pharma (CPH) is officially dual listed, after completing its listing on the US OTCQB stock exchange
  • The cannabis business will commence trading on the US market on today (Friday, June 11) under the ticker code COPHF
  • CPH says its new listing will better expose the company to North American investors, ahead of its US pharmaceutical market entry
  • The company is in the process of acquiring Halucenex, a Canadian business that is involved in researching psychedelics
  • Creso Pharma shares are up 12.5 per cent at 18 cents each at 11:18 am AEST

Creso Pharma (CPH) is officially dual listed, after completing its listing on the US OTCQB stock exchange.

The cannabis business will commence trading on the US market today (Friday, June 11) under the ticker code COPHF.

CPH said the new listing would better expose the company to North American investors and align with its plans to enter the region's pharmaceutical market.

The company is also in the process of acquiring Halucenex, a Canadian business that is involved in researching psychedelics

"The company’s dual listing coincides with the growth Creso Pharma has achieved recently in the US and North America more broadly," Non-Executive Chairman Adam Blumenthal said.

Mr Blumenthal explained CPH had already assigned John Griese as its American leader to help navigate the US market entry.

"Recently, we have been focused on laying a very strong foundation in the region, which is underpinned by the expansion of operations and key appointments that will provide a number of value catalysts for both Australian and North American investors," Mr Blumenthal said.

"The cannabis and psychedelic medicines sectors continue to gain considerable momentum.

"Recent regulatory shifts have left the company in a favourable position and Creso is well placed to become a global leader across both sectors."

Following today's announcement, Creso Pharma shares were up 12.5 per cent at 18 cents each at 11:18 am AEST.

CPH by the numbers
More From The Market Herald
The Market Herald Video

" US regulator approves expanded use of Avita Medical’s (ASX:AVH) RECELL System

The US regulator has approved the expanded use of Avita Medical’s (AVH) RECELL system in combination with meshed autographs to treat burns patients.
Advanced Human Imaging (ASX:AHI) - CEO, Vlado Bosanac - The Market Herald

" Advanced Human Imaging (ASX:AHI) signs term sheet with Cubert

Advanced Human Imaging (AHI) has signed a binding term sheet with Toronto-based digital health provider Cubert Inc.
Microequities Asset Management (ASX:MAM) posts 140pc boost to half-yearly profit

" Patrys (ASX:PAB) receives $600k R&D tax incentive refund

Patrys (PAB), through its wholly owned Nucleus Therapeutics subsidiary, has received a research and development (R&D) tax incentive refund of $626,780 for the
Medibio (ASX:MEB) illuminates mental health in the U.K.

" Oneview Healthcare (ASX:ONE) extends Epworth contract by five years

Oneview Healthcare (ONE) has penned a five-year contract extension with Victoria-based Epworth Healthcare.